Complement and its implications in cardiac ischemia/reperfusion: strategies to inhibit complement
- 24 October 2001
- journal article
- review article
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 15 (5), 293-306
- https://doi.org/10.1046/j.1472-8206.2001.00040.x
Abstract
Although reperfusion of the ischemic myocardium is an absolute necessity to salvage tissue from eventual death, it is also associated with pathologic changes that represent either an acceleration of ...Keywords
This publication has 100 references indexed in Scilit:
- Pharmacological characterization of antagonists of the C5a receptorBritish Journal of Pharmacology, 1999
- Anti-C5a monoclonal antibody reduces cardiopulmonary bypass and cardioplegia-induced coronary endothelial dysfunctionThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Complement deficiency and autoimmunityCurrent Opinion in Pediatrics, 1998
- Attenuation of Interleukin-8 Expression in C6-deficient Rabbits After Myocardial Ischemia/ReperfusionJournal of Molecular and Cellular Cardiology, 1998
- Influence of the terminal complement-complex on reperfusion injury, no-reflow and arrhythmias: a comparison between C6-competent and C6-deficient rabbitsCardiovascular Research, 1996
- A soluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathwayEuropean Journal of Immunology, 1996
- Decapeptide agonists of human C5a: the relationship between conformation and neutrophil responseJournal of Medicinal Chemistry, 1995
- Therapeutic uses of recombinant complement protein inhibitorsSpringer Seminars in Immunopathology, 1994
- Quantitative measurement of SC5b-9 and C5b-9(m) in infarcted areas of human myocardiumClinical and Experimental Immunology, 1990
- The effect of FUT-175 (nafamstat mesilate) on C3a, C4a and C5a generation in vitro and inflammatory reactions in vivoInternational Journal of Immunopharmacology, 1990